Home > Insider Trading > Corcept Therapeutics Inc > Profile

Corcept Therapeutics Inc (CORT)

Market is closed

Sector: Pharmaceutical Preparations

Related Insiders

Jr N Daniel Swisher, , 2024-12-12
William Guyer, Chief Development Officer, 2024-12-05
Sean Maduck, See Remarks, 2024-12-05

Jr N Daniel Swisher, , 2024-12-12
William Guyer, Chief Development Officer, 2024-12-05
Sean Maduck, See Remarks, 2024-12-05
Charles Gary Robb, Chief Business Officer, 2024-12-05
Douglas Joseph Lyon, See Remarks, 2024-12-05
Atabak Mokari, Chief Financial Officer, 2024-12-05
Hazel Hunt, Chief Scientific Officer, 2024-08-05
K Joseph Belanoff, Chief Executive Officer, 2024-08-02
N James Wilson, , 2024-05-28
Kimberly Park, , 2024-05-21
M. Joshua Murray, , 2024-05-21
H Gregg Alton, , 2024-05-21
L David Mahoney, , 2024-05-21
Jr Leonard G Baker, Director, 2024-05-21
Gillian Cannon, , 2024-05-21
Andreas Grauer, Chief Medical Officer, 2021-02-08
Daniel Bradbury, Director, 2019-02-13
S Robert Fishman, Chief Medical Officer, 2018-11-09
D Renee Gala, Director, 2018-08-22
G Patrick Enright, Director, 2017-03-20
Juliet Bakker Tammenoms, Large Shareholder, 2016-12-19
L.p. Partners Venture Longitude, Large Shareholder, 2016-12-01
Longitude Capital Partners, Llc, Large Shareholder, 2016-12-01
Longitude Capital Associates, L.p., Large Shareholder, 2016-12-01
Steven Lo, Svp Oncology, 2015-11-16
M Anne Ledoux, Vp & Controller, 2015-09-29
L Joseph Turner, Director, 2015-06-23
Jr C Joseph Cook, Director, 2015-06-23
Iii J Samuel Pullara, Large Shareholder, 2013-07-11
A Stefan Dyckerhoff, Large Shareholder, 2013-07-11
Jr H William Younger, Other, 2013-02-14
L David Anderson, Other, 2013-02-14
Tench Coxe, Other, 2013-02-14
C James Gaither, Other, 2013-02-14
L Robert Roe, President And Secretary, 2013-02-02
N James White, Large Shareholder, 2012-04-02
Ventures Hill Sutter, Large Shareholder, 2012-04-02
E David Sweet, Large Shareholder, 2012-04-02
L Michael Speiser, Large Shareholder, 2012-04-02
T Andrew Sheehan, Large Shareholder, 2012-04-02
W Jeffrey Bird, Large Shareholder, 2012-04-02
P Gregory Sands, Large Shareholder, 2011-10-25
A James Harper, Director, 2010-07-12
Edward Penhoet, Large Shareholder, 2010-04-06
Alta Biopharma Partners Ii Lp Alta Biopharma Management Ii L, Large Shareholder, 2009-10-20
Allen Andersson, Director, 2009-06-29
Paperboy Ventures, Llc, Director, 2009-05-11

Show All Insiders (47)

Hedge Fund Popularity

Display

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on November 14, 2024, 4:20 pm based on SEC 13F filings Last update: November 14, 2024, 4:20 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Renaissance Technologies Jim Simons	6,509,002	$301,236,613	-6%	0.45%
2.	Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell	1,580,621	$73,151,140	+7%	0.06%
3.	D E Shaw D. E. Shaw	788,064	$36,471,602	-17%	0.03%
4.	Two Sigma Advisors John Overdeck And David Siegel	457,100	$21,154,588	-12%	0.04%
5.	Royce & Associates Chuck Royce	363,272	$16,812,228	+4%	0.15%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Baker	$21.53	100,000	Director	3,308,303	2021-06-11	Filing
Baker	$21.53	50,000	Director	1,046,838	2021-06-11	Filing
Baker	$22.64	68	Director	3,208,303	2020-12-01	Filing
Baker	$22.80	1,109	Director	3,208,235	2020-11-30	Filing
Baker	$22.81	361	Director	3,207,126	2020-11-25	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Remaining Holdings	Date	Form 4
Swisher	$59.46	2,200	0	2024-12-10	Filing
Robb	$56.20	2,609	20,163	2024-11-22	Filing
Lyon	$56.72	1,411	8,494	2024-11-22	Filing
Swisher	$59.88	2,200	0	2024-11-11	Filing
Guyer	$48.97	3,394	5,796	2024-11-04	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Blackrock Inc.	16,407,696	$532,921,965	0.01%
2.	Vanguard Group Inc	9,537,532	$309,779,039	0%
3.	Parallel Advisors, Llc	3,768,245	$122,392,598	3.63%
4.	State Street Corp	3,387,465	$110,024,863	0%
5.	Novo A/s	2,411,362	$78,321,038	4.83%

News See All

Click here to See All News